Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake

Not Applicable

Completed

• Conditions: HPV-Related Cervical Carcinoma
• Interventions: Other: Control; Other: Educational video; Other: Educational handout

• Registration Number: NCT03337269
• Lead Sponsor: University of Pennsylvania

Brief Summary

This study aims to assess the effectiveness of targeted educational interventions in increasing the acceptability and knowledge of the HPV vaccine among females ages 12 through 26. Subjects will be randomized to one of three study arms (no intervention, viewing an educational video or reading an educational handout) and then a questionnaire will be administered to assess knowledge and acceptability of the HPV vaccine. Subject charts will be reviewed to assess for initiation of the HPV vaccine.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-03-01
• Primary Completion: 2017-08-15
• Study First Submitted: 2017-09-13
• Study First Submitted QC: 2017-11-06
• Study First Posted: 2017-11-08
• Study Completion: 2018-02-15
• Status Verified: 2018-04
• Last Update Submitted: 2018-04-09
• Last Update Posted: 2018-04-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 256

Inclusion Criteria

1. Females ages greater than or equal to 12 years and less than or equal to 26 years
2. Presenting to a gynecology clinic for a routine or problem visit
3. Ability to read and write

Read More

Exclusion Criteria

1. Women ages less than or greater than 12 years or greater than 26 years
2. Women with known cervical cancer
3. Known pregnancy
4. Prior initiation or completion of the HPV vaccine series

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Control	Control	Subject does not receive an educational intervention
Educational video	Educational video	Subject watches an educational video
Educational handout	Educational handout	Subject reads an educational handout

Primary Outcome Measures

Name	Time	Method
HPV vaccine acceptability	Up to 6 months	Subject reported willingness to accept the HPV vaccination, as assessed through agreement or disagreement to the statement "I would be willing to accept the HPV vaccine today."

Secondary Outcome Measures

Name	Time	Method
HPV vaccine knowledge	Up to 6 months	Subject knowledge of the HPV vaccine and its associated risks and benefits, as assessed through a survey. Subjects are asked to answer 7 questions and total knowledge score is calculated by an unweighted sum of correct answers.

Trial Locations

Locations (1)

University of Pennsylvania; 🇺🇸 Philadelphia, Pennsylvania, United States